U.S. Stem Cell (USRM) Short Interest Ratio & Short Volume

Short interest is the volume of U.S. Stem Cell shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 1,400 shares of USRM short. Learn More on U.S. Stem Cell's current short interest.

U.S. Stem Cell saw a increase in short interest in June. As of June 30th, there was short interest totaling 1,400 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "business services" compare to U.S. Stem Cell: Signing Day Sports, Inc. (13.96%), Starbox Group Holdings Ltd. (1.63%), Innovaro, Inc. (0.00%), Protocall Technologies Inc. (0.14%), Digital Locations, Inc. (0.02%), EVmo, Inc. (0.03%), Kingold Jewelry, Inc. (0.03%), and Mullen Automotive, Inc. (118.78%).

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($3.35 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.80 billion), Coinbase Global, Inc. ($2.58 billion), Royal Caribbean Cruises Ltd. ($2.17 billion), Moderna, Inc. ($2.13 billion), T. Rowe Price Group, Inc. ($2.11 billion), Palantir Technologies Inc. ($2.03 billion), Extra Space Storage Inc. ($1.81 billion), and Verisk Analytics, Inc. ($1.63 billion). View all of the most shorted stocks.

Short selling USRM is an investing strategy that aims to generate trading profit from U.S. Stem Cell as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for U.S. Stem Cell occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of USRM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including USRM, twice per month. The most recent reporting period available is June, 30 2023.